TrialAntimicrobial agents and chemotherapy2022

Integrase Inhibitor Resistance Mechanisms and Structural Characteristics in Antiretroviral Therapy-Experienced, Integrase Inhibitor-Naive Adults with HIV-1 Infection Treated with Dolutegravir plus Two Nucleoside Reverse Transcriptase Inhibitors in the DAWNING Study.

Mark Underwood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.